Sirtinol, a SIRT1 inhibitor, inhibits the EMT and metastasis of 4T1 breast cancer cells and impacts the tumor microenvironment

Sirtinol, a SIRT1 inhibitor inhibits EMT and metastasis of 4T1 breast cancer cells and also has an impact on the immune microenvironment.

Authors

Institutions

Publication Details

Journal
Immunopharmacology and Immunotoxicology
Published
2024-10-07
DOI
https://doi.org/10.1080/08923973.2024.2412110
Citations
5
Primary Topic
Sirtuins and Resveratrol in Medicine
Type
article
Field-Weighted Citation Impact
1.72

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Sirtinol, a SIRT1 inhibitor, inhibits the EMT and metastasis of 4T1 breast cancer cells and impacts the tumor microenvironment

Kavitha Premkumar, Bhavani S. Shankar, Nitya Palekar, Sharvari Satam
5 citations
Immunopharmacology and Immunotoxicology
Sirtuins and Resveratrol in Medicine
1.72
article

Sirtinol, a SIRT1 inhibitor, inhibits the EMT and metastasis of 4T1 breast cancer cells and impacts the tumor microenvironment

Kavitha Premkumar, Bhavani S. Shankar, Nitya Palekar, Sharvari Satam
article en
5 citations

Abstract

Sirtinol, a SIRT1 inhibitor inhibits EMT and metastasis of 4T1 breast cancer cells and also has an impact on the immune microenvironment.

Immunopharmacology and ImmunotoxicologyVol. 46(6)
Bhabha Atomic Research Centre (IN), Homi Bhabha National Institute (IN)
Bhabha Atomic Research Centre
Good health and well-being
Openalex Percentile: Top 15%
Sirtuins and Resveratrol in Medicine
1.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Sirtinol, a SIRT1 inhibitor, inhibits the EMT and metastasis of 4T1 breast cancer cells and impacts the tumor microenvironment — Kavitha Premkumar, Bhavani S. Shankar, et al. · Immunopharmacology and Immunotoxicology (2024) | TGRS Research Map | TGRS